November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
July 30, 2015
DPR gets its own cell communications provider
Incident Prevention Response Mechanism participants discuss security issues at border between South Ossetia, Georgia
Georgian citizen detained in S. Ossetia on suspicion of espionage to be sent home via Red Cross
PARNAS party submits list of candidates to run in elections in Kostroma region
Four people hurt in WIG vehicle crash in Karelia
New Moldovan government takes oath
Ruble starts sliding again after yesterday's correction
Main indexes of the Russia stock market for July 30
Mosenergo H1 net profit to RAS down 9.7% to 6.9 bln rubles (Part 2)
Russian shares up on oil, MICEX surges as ruble weakens
Moscow City Court to consider appeal contesting sentence of people convicted in Oboronservice case, including Vasilyeva, on August 12 (Part 2)
Total of 225 unknown participants of forceful operation in southeastern Ukraine buried in Dnipropetrovsk - administration
Mine on fire in Donetsk's Makiivka, 103 miners saved